Wing M Ho
Overview
Explore the profile of Wing M Ho including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
666
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ho W, Gorke A, Petr O, Thome C
J Neurosurg Sci
. 2017 Nov;
62(2):178-186.
PMID: 29125267
Spinal vascular malformations are a rare heterogeneous entity of spinal lesions with abnormal blood vessels. They may occur extra- and intradurally, peri- and intramedullary, with confined or complex configuration, and...
2.
Enkhjargal B, Malaguit J, Ho W, Jiang W, Wan W, Wang G, et al.
J Cereb Blood Flow Metab
. 2017 Aug;
39(2):272-284.
PMID: 28825325
The role of vitamin D3 (VitD3) in the upregulation of osteopontin (OPN) and eNOS in the endothelium of cerebral arteries after subarachnoid hemorrhage (SAH) is investigated. The endovascular perforation SAH...
3.
Ma B, Mo F, Tong J, Wong A, Wong S, Ho W, et al.
Asia Pac J Clin Oncol
. 2015 Apr;
11(2):160-9.
PMID: 25865669
Aim: The prognostic significance of KRAS, NRAS, PIK3CA and BRAF mutations was evaluated in Chinese patients with metastatic colorectal cancer (CRC). Method: Tumor samples from 183 patients were retrospectively tested...
4.
Ma B, Chan S, Ho W, Lau W, Mo F, Hui E, et al.
Cancer
. 2013 Oct;
119(23):4145-53.
PMID: 24114668
Background: This study evaluated the activity of 2 schedules of erlotinib in combination with chemotherapy, and the prognostic significance of serum amphiregulin (AREG) and transforming growth factor alpha (TGFa) in...
5.
Au A, Lam W, Tsang J, Yau T, Soong I, Yeo W, et al.
Psychooncology
. 2012 Jun;
22(5):1144-51.
PMID: 22715115
Background: Women with advanced breast cancer (ABC) are living longer, so understanding their needs becomes important. This cross-sectional study investigated the type and extent of unmet supportive care needs in...
6.
Lee Y, Hung Y, Mo F, Ho W
Int J Nurs Pract
. 2010 Sep;
16(5):508-16.
PMID: 20854349
Folfox and Folfiri are active chemotherapy treatments used in advanced colorectal cancer. The total admission for these treatments has been significantly increasing in the study hospital. An ambulatory infusion programme...
7.
Chan S, Mo F, Johnson P, Hui E, Ma B, Ho W, et al.
J Clin Oncol
. 2008 Dec;
27(3):446-52.
PMID: 19064965
Purpose: There are limitations in using radiologic evaluation to assess the treatment outcome of patients with hepatocellular carcinoma (HCC). The use of serial alpha-fetoprotein (AFP) in monitoring response has not...
8.
Yeo W, Mo F, Chan S, Leung N, Hui P, Lam W, et al.
Hepatology
. 2007 Jun;
45(6):1382-9.
PMID: 17539025
Unlabelled: HCC is a common cause of morbidity and mortality. For patients who are not candidates for curative surgery, systemic chemotherapy is one of the standard treatments. In parts of...
9.
Yeo W, Mok T, Zee B, Leung T, Lai P, Lau W, et al.
J Natl Cancer Inst
. 2005 Oct;
97(20):1532-8.
PMID: 16234567
Background: Single-agent doxorubicin has been widely used to treat unresectable hepatocellular carcinoma (HCC), but the response rate is low (< 20%) and there is no convincing evidence for improved survival....
10.
Ho W, Ma B, Mok T, Yeo W, Lai P, Lim R, et al.
Med Oncol
. 2005 Aug;
22(3):303-12.
PMID: 16110141
The main objectives of this study were to assess the use of irinotecan, 5-fluorouracil (5-FU), and leucovorin (FA) as neoadjuvant chemotherapy for patients with unresectable colorectal liver metastases and to...